$228.84
0.11%
Nasdaq, Jan 02, 10:04 pm CET
ISIN
US6323071042
Symbol
NTRA

Natera, Inc. Stock price

$228.84
-7.80 3.30% 1M
+67.27 41.64% 6M
-0.25 0.11% YTD
+68.24 42.49% 1Y
+188.67 469.68% 3Y
+132.53 137.61% 5Y
+218.50 2,113.15% 10Y
+206.10 906.33% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
-0.25 0.11%
ISIN
US6323071042
Symbol
NTRA
Industry

New AI Insights on Natera, Inc. Insights AI Insights on Natera, Inc.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$31.7b
Enterprise Value
$30.7b
Net debt
positive
Cash
$1.0b
Shares outstanding
137.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
15.0 | 14.0
EV/Sales
14.5 | 13.6
EV/FCF
328.0
P/B
25.3
Financial Health
Equity Ratio
72.0%
Return on Equity
-15.9%
ROCE
-25.5%
ROIC
-50.1%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$2.1b | $2.3b
EBITDA
$-314.7m | $-330.0m
EBIT
$-351.9m | $-367.5m
Net Income
$-309.2m | $-336.6m
Free Cash Flow
$93.6m
Growth (TTM | estimate)
Revenue
38.2% | 33.2%
EBITDA
-48.4% | -72.5%
EBIT
-45.3% | -65.3%
Net Income
-44.0% | -76.8%
Free Cash Flow
314.2%
Margin (TTM | estimate)
Gross
63.7%
EBITDA
-14.9% | -14.6%
EBIT
-16.6%
Net
-14.6% | -14.9%
Free Cash Flow
4.4%
More
EPS
$-2.3
FCF per Share
$0.7
Short interest
2.5%
Employees
4k
Rev per Employee
$380.0k
Show more

Is Natera, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Natera, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Natera, Inc. forecast:

24x Buy
89%
3x Hold
11%

Analyst Opinions

27 Analysts have issued a Natera, Inc. forecast:

Buy
89%
Hold
11%

Financial data from Natera, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,117 2,117
38% 38%
100%
- Direct Costs 769 769
19% 19%
36%
1,347 1,347
53% 53%
64%
- Selling and Administrative Expenses 1,121 1,121
46% 46%
53%
- Research and Development Expense 578 578
62% 62%
27%
-315 -315
48% 48%
-15%
- Depreciation and Amortization 37 37
24% 24%
2%
EBIT (Operating Income) EBIT -352 -352
45% 45%
-17%
Net Profit -309 -309
44% 44%
-15%

In millions USD.

Don't miss a Thing! We will send you all news about Natera, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Natera, Inc. Stock News

Positive
Investors Business Daily
4 days ago
Natera stock is near its all-time high after gaining 46% year to date.
Neutral
Business Wire
13 days ago
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, Jan. 13, 2026 at 4:30 p.m. PT (7:30 p.m. ET). Members of management will deliver a presentation and host a Q&A with the investment community at the conf...
Neutral
Business Wire
17 days ago
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of findings from the randomized, phase III CALGB (Alliance)/SWOG 80702 study in JAMA Oncology. This publication builds on the initial presentation of results at the 2025 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium (A...
More Natera, Inc. News

Company Profile

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

Head office United States
CEO Stephen Chapman
Employees 4,429
Founded 2004
Website www.natera.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today